These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8133794)

  • 1. Gynecologic complications of cyclic estrogen progestin therapy.
    Ettinger B; Selby JV; Citron JT; Ettinger VM; Zhang D
    Maturitas; 1993 Nov; 17(3):197-204. PubMed ID: 8133794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension.
    Sriprasert I; Beydoun H; Barnabei V; Nassir R; LaCroix AZ; Archer DF
    Menopause; 2015 Oct; 22(10):1067-75. PubMed ID: 25756697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uterus and the menopause.
    Rees MC
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):419-32. PubMed ID: 8931903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynecologic consequences of long-term, unopposed estrogen replacement therapy.
    Ettinger B; Golditch IM; Friedman G
    Maturitas; 1988 Dec; 10(4):271-82. PubMed ID: 3226337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected vaginal bleeding and associated gynecologic care in postmenopausal women using hormone replacement therapy: comparison of cyclic versus continuous combined schedules.
    Ettinger B; Li DK; Klein R
    Fertil Steril; 1998 May; 69(5):865-9. PubMed ID: 9591494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical inquiries. What is the best diagnostic approach to postmenopausal vaginal bleeding in women taking hormone replacement therapy?
    Kerns JW; Mabry S; Lopez R
    J Fam Pract; 2001 Oct; 50(10):843-4. PubMed ID: 11674884
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.
    Anderson GL; Judd HL; Kaunitz AM; Barad DH; Beresford SA; Pettinger M; Liu J; McNeeley SG; Lopez AM;
    JAMA; 2003 Oct; 290(13):1739-48. PubMed ID: 14519708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
    Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
    Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer.
    Pike MC; Ross RK
    Steroids; 2000; 65(10-11):659-64. PubMed ID: 11108873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic hormone replacement therapy using quarterly progestin.
    Ettinger B; Selby J; Citron JT; Vangessel A; Ettinger VM; Hendrickson MR
    Obstet Gynecol; 1994 May; 83(5 Pt 1):693-700. PubMed ID: 8164927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of estrogen/progestogen receptors in the endometrium.
    Casper RF
    Int J Fertil Menopausal Stud; 1996; 41(1):16-21. PubMed ID: 8673152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvaginal ultrasonographic measurement of endometrial thickness in postmenopausal women receiving estrogen replacement therapy.
    Holbert TR
    Am J Obstet Gynecol; 1997 Jun; 176(6):1334-8; discussion 1338-9. PubMed ID: 9215193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbances of endometrial bleeding with hormone replacement therapy.
    Thomas AM; Hickey M; Fraser IS
    Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical aspects of hormone replacement therapy.
    Thorneycroft IH
    Prog Cardiovasc Dis; 1995; 38(3):243-54. PubMed ID: 7494885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and management of abnormal uterine bleeding in premenopausal women.
    Sweet MG; Schmidt-Dalton TA; Weiss PM; Madsen KP
    Am Fam Physician; 2012 Jan; 85(1):35-43. PubMed ID: 22230306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.